Immunoblotting Reveals Differences in the Accumulation of Envelope Protein by Wild-type and Vaccine Strains of Yellow Fever Virus

References

1. Buckley A., Gould E. A. 1985; Neutralization of yellow fever virus studied using monoclonal and polyclonal antibodies. Journal of General Virology 66:2523–2531
   [Google Scholar]
2. Cammack N., Gould E. A. 1986; Antigenic analysis of yellow fever virus glycoproteins: use of monoclonal antibodies in enzyme-linked immunosorbent assays. Journal of Virological Methods 13:135–142
   [Google Scholar]
3. Clarke D. H. 1960; Antigenic analysis of certain group B arthropod-borne viruses by antibody absorption. Journal of Experimental Medicine 111:21–32
   [Google Scholar]
4. Deubel V., Digoutte J.-P., Monath T. P., Girard M. 1986; Genetic heterogeneity of yellow fever virus strains from Africa and the Americas. Journal of General Virology 67:209–213
   [Google Scholar]
5. Deubel V., Schlesinger J. J., Digoutte J.-P., Girard M. 1987; Comparative immunochemical and biological analysis of African and South American yellow fever viruses. Archives of Virology 94:331–338
   [Google Scholar]
6. Fitzgeorge R., Bradish C. J. 1980; The in vivo differentiation of strains of yellow fever virus in mice. Journal of General Virology 46:1–13
   [Google Scholar]
7. Gould E. A., Buckley A., Cammack N., Barrett A. D. T., Clegg J. C. S., Ishak R., Varma M. G. R. 1985; Examination of the immunological relationships between the flaviviruses using yellow fever virus monoclonal antibodies. Journal of General Virology 66:1369–1382
   [Google Scholar]
8. Gould E. A., Buckley A., Groeger B. K., Cane P. A., Doenhoff M. 1987; Immune enhancement of yellow fever virus neurovirulence for mice: studies of mechanisms involved. Journal of General Virology 68:3105–3112
   [Google Scholar]
9. Hahn C S., Dalrymple J. M., Strauss J. H., Rice C. M. 1987; Comparison of The Virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it. Proceedings of the National Academy of SciencesU.S.A 842019–2023
   [Google Scholar]
10. Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, London 227:680–685
    [Google Scholar]
11. Monath T. P., Kinney R. M., Schlesinger J. J., Brandriss M. W., Bres P. 1983; Ontogeny of yellow fever 17D vaccine: RNA oligonucleotide fingerprint and monoclonal antibody analyses of vaccines produced worldwide. Journal of General Virology 64:627–637
    [Google Scholar]
12. Porterfield J. S. 1980; Antigenic characteristics and classification of Togaviridae. In The Togaviruses13–46 Schlesinger R. W. New York & London: Academic Press;
    [Google Scholar]
13. Schlesinger J. J., Brandriss M. W., Monath T. P. 1983; Monoclonal antibodies distinguish between wild and vaccine strains of yellow fever virus by neutralization, hemagglutination inhibition, and immune precipitation of the virus envelope protein. Virology 125:8–17
    [Google Scholar]
14. Srivastava A. K., Aira Y., Mori C, Kobayashi Y., Igarashi A. 1987; Antigenicity of Japanese encephalitis virus envelope glycoprotein V 3 (E) and its cyanogen bromide cleaved fragments examined by monoclonal antibodies and Western blotting. Archives of Virology 96:97–107
    [Google Scholar]
15. Theiler M., Smith H. H. 1937; Effect of prolonged cultivation in vitro upon pathogenicity of yellow fever virus. Journal of Experimental Medicine 65:767–786
    [Google Scholar]
16. Wengler G., Wengler G., Nowak T., Wahn K. 1987; Analysis of the influence of proteolytic cleavage on the structural organization of the surface of the West Nile flavivirus leads to the isolation of a protease-resistant E protein oligomer from the viral surface. Virology 160:210–219
    [Google Scholar]